title: Detection of Mycoplasma genitalium-reactive cervicovaginal antibodies among infected women.
abstract: Mycoplasma genitalium-reactive cervicovaginal IgA and IgG antibodies were detected in 51.9% and 70.4% of 27 infected women and 22.2% and 18.5% of 27 uninfected controls, respectively. The predominance of MgpB- and MgpC-reactive antibodies at the site of infection is consistent with their hypothesized role in selecting antigenic variants during persistent infection.
authors.affiliation: Department of Global Health, University of Washington, Seattle, Washington, USA. slic@u.washington.edu
authors.forename: Stefanie L
authors.initials: SL
authors.lastname: Iverson-Cabral
authors.forename: Lisa E
authors.initials: LE
authors.lastname: Manhart
authors.forename: Patricia A
authors.initials: PA
authors.lastname: Totten
mesh_terms: D000907:Antibodies, Bacterial / Q000032:analysis*; D000942:Antigens, Bacterial; D002584:Cervix Uteri / Q000276:immunology*; D005260:Female; D006801:Humans; D007070:Immunoglobulin A / Q000032:analysis; D007074:Immunoglobulin G / Q000032:analysis; D009175:Mycoplasma Infections / Q000276:immunology*; D045704:Mycoplasma genitalium / Q000276:immunology*; D014621:Vagina / Q000276:immunology*; D044364:Vaginal Douching
chemical_list: D000907:Antibodies, Bacterial; D000942:Antigens, Bacterial; D007070:Immunoglobulin A; D007074:Immunoglobulin G